纵横研报
Ticker Detail

600521.SHG

¥16.89-0.47% 华海药业 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Zhejiang Huahai Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. Further, it operates as a pharmaceutical company. Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.

MARKET 市值 25.21B CNY PE 70.2x Fwd 26.2x 52W ¥13.73 – ¥27.97 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 1.54 营收 YoY -1.4% ROE 3.3% 营业利润率 13.2% 净利润率 4.4%
ANALYST 股息率 0.62%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制